News Search

Carol M. Troy, MD, PhD, Professor of Pathology & Cell Biology and Neurology at CUMC, discusses, based on a new study, how eye drops could be more effective in treating retinal vein occlusion

Dr. Lawrence S. Honig, Professor of Neurology at the CUIMC, comments on the significance of Food and Drug Administration approval of the Alzheimer’s disease drug, Lecanemab

Lawrence S. Honig, MD, PhD, Professor of Neurology at the CUIMC, an investigator for the study that led to the FDA’s approval of Leqembi expresses his opinions about the new Alzheimer’s Disease drug